Market Value116,785,040
Total Holdings53
File Date2024-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
LLY / Eli Lilly and Company
CLDX / Celldex Therapeutics, Inc.
ESTA / Establishment Labs Holdings Inc.
RDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)
OCUL / Ocular Therapeutix, Inc.
PLRX / Pliant Therapeutics, Inc.
AGIO / Agios Pharmaceuticals, Inc.
ELVN / Enliven Therapeutics, Inc.
TVTX / Travere Therapeutics, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
PACB / Pacific Biosciences of California, Inc.
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
INSM / Insmed Incorporated
MOR / MorphoSys AG - Depositary Receipt (Common Stock)
OLMA / Olema Pharmaceuticals, Inc.
NARI / Inari Medical, Inc.
VRTX / Vertex Pharmaceuticals Incorporated
MRNS / Marinus Pharmaceuticals, Inc.
CABA / Cabaletta Bio, Inc.
PROC / Procaps Group S.A.
QTTB / Q32 Bio Inc.
DXCM / DexCom, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
ADAG / Adagene Inc. - Depositary Receipt (Common Stock)
AVTE / Aerovate Therapeutics, Inc.
ARWR / Arrowhead Pharmaceuticals, Inc.
ELEV / Elevation Oncology, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
GRCL / Gracell Biotechnologies Inc. - Depositary Receipt (Common Stock)
MGNX / MacroGenics, Inc.
STTK / Shattuck Labs, Inc.
MRTX / Mirati Therapeutics, Inc.
IMGN / ImmunoGen, Inc.
EYPT / EyePoint Pharmaceuticals, Inc.
KNTE / Kinnate Biopharma Inc.
STRO / Sutro Biopharma, Inc.
CPRX / Catalyst Pharmaceuticals, Inc.
SAGE / Sage Therapeutics, Inc.
TGTX / TG Therapeutics, Inc.
SWAV / Shockwave Medical, Inc.
ALPN / Alpine Immune Sciences, Inc.
ITCI / Intra-Cellular Therapies, Inc.
BIIB / Biogen Inc.
INZY / Inozyme Pharma, Inc.
RGLS / Regulus Therapeutics Inc.
KRYS / Krystal Biotech, Inc.
SGMT / Sagimet Biosciences Inc.
PEN / Penumbra, Inc.
APLS / Apellis Pharmaceuticals, Inc.
TARS / Tarsus Pharmaceuticals, Inc.
NTRA / Natera, Inc.
EXAS / Exact Sciences Corporation
IMTX / Immatics N.V.
LNTH / Lantheus Holdings, Inc.
TSHA / Taysha Gene Therapies, Inc.
IGMS / IGM Biosciences, Inc.
MLTX / MoonLake Immunotherapeutics
PRTA / Prothena Corporation plc
AVRO / AVROBIO, Inc.
TERN / Terns Pharmaceuticals, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
CYTK / Cytokinetics, Incorporated
INBX / Inhibrx Biosciences, Inc.
ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
BHVN / Biohaven Ltd.
GERN / Geron Corporation
CRBP / Corbus Pharmaceuticals Holdings, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
VYNE / VYNE Therapeutics Inc.
ISRG / Intuitive Surgical, Inc.
RNA / Avidity Biosciences, Inc.
QTRX / Quanterix Corporation
BBIO / BridgeBio Pharma, Inc.
CI / The Cigna Group
IMAB / I-Mab - Depositary Receipt (Common Stock)
VTYX / Ventyx Biosciences, Inc.
RGNX / REGENXBIO Inc.
GH / Guardant Health, Inc.